33 institutional investors are raising stakes in Corium International, Inc. (CORI)

Corium International, Inc. (NASDAQ:CORI) enjoyed a 349.24% run-up in share price since hitting record low of $2.67. The stock managed 6.29% rise and now stands at $12 as of 11/24/2017. At recent session, the prices were hovering between $11.3 and $12.08. This company shares are 8.33% off its target price of $13 and the current market capitalization stands at $401.16M. The recent change has given its price a 14.49% lead over SMA 50 and -1.48% deficit over its 52-week high. The stock witnessed 22.45% gains, 43.37% gains and 68.78% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found CORI’s volatility during a week at 9.28% and during a month it has been found around 6.71%.

Corium International, Inc. (CORI) Top Holders

Institutional investors currently hold around $366 million or 90.9% in CORI stock. Look at its top three institutional owners. Essex Woodlands Health Ventures, Inc. owns $105.6 million in Corium International, Inc., which represents roughly 26.32% of the company’s market cap and approximately 28.85% of the institutional ownership. Similar statistics are true for the second largest owner, Perceptive Advisors Llc, which owns 5,847,133 shares of the stock are valued at $66.01 million. The third largest holder is Broadfin Capital, Llc, which currently holds $50.09 million worth of this stock and that ownership represents nearly 12.49% of its market capitalization.

Corium International, Inc. 13F Filings

At the end of 09/30/2017 reporting period, 33 institutional holders increased their position in Corium International, Inc. (NASDAQ:CORI) by some 1,184,227 shares, 16 decreased positions by 1,289,250 and 14 held positions by 29,903,173. That puts total institutional holdings at 32,376,650 shares, according to SEC filings. The stock grabbed 10 new institutional investments totaling 194,659 shares while 5 institutional investors sold out their entire positions totaling 434,830 shares.

Corium International, Inc. (NASDAQ:CORI) Insider Trades

Multiple company employees have indulged in significant insider trading. Corium International, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that 10% Owner Broadfin Healthcare Master Fun has sold 500,000 shares of Corium International, Inc. (CORI) in trading session dated Nov. 17, 2017. These shares are worth $5,480,000 and were traded at $10.96 each. The SEC filing shows that Broadfin Healthcare Master Fun performed a sale of 150,000 shares. The 10% Owner disposed these shares by way of transaction on Nov. 02, 2017. The company’s shares were given away at $11.05 per share worth to an income of some $1,657,500 on account of Broadfin Healthcare Master Fun.

10% Owner, Broadfin Healthcare Master Fun, sold 218,100 common shares of Corium International, Inc. (CORI) in the open market. In a transaction dated Oct. 04, 2017, the shares were put up for sale at an average price of $11.01, raking in a sum of $2,401,281. After this sale, 4,218,626 common shares of CORI are directly owned by the insider, with total stake valued at $50,623,512.

In the transaction dated Aug. 22, 2017, the great number of shares disposed came courtesy the CTO & Vice President, R&D; Singh Parminder disposed a total of 30,415 shares at an average price of $7.59, amounting to approximately $230,850. The insider now directly owns 7,940 shares worth $95,280.

Corium International, Inc. (CORI) Analyst Guide

Several analysts have released their opinion on Corium International, Inc. (NASDAQ:CORI), with 3 analysts believing it is a strong buy. Whereas 0 of them predict the stock is a hold. Also, there are 1 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1.25 average brokerage recommendation.

SHARE